[1]
Espejo-Román, J.M.; Rubio-Ruiz, B.; Cano-Cortés, V.; Cruz-López, O.; Gonzalez-Resines, S.; Domene, C.; Conejo-García, A.; Sánchez-Martín, R.M. Selective anticancer therapy based on a HA-CD44 interaction inhibitor loaded on polymeric nanoparticles. Pharmaceutics, 2022, 14(4), 788.
[http://dx.doi.org/10.3390/pharmaceutics14040788]
[http://dx.doi.org/10.3390/pharmaceutics14040788]
[2]
Cruz-López, O.; Ner, M.; Nerín-Fonz, F.; Jiménez-Martínez, Y.; Araripe, D.; Marchal, J.A.; Boulaiz, H.; Gutiérrez-de-Terán, H.; Campos, J.M.; Conejo-García, A. Design, synthesis, HER2 inhibition and anticancer evaluation of new substituted 1,5-dihydro-4,1-benzoxazepines. J. Enzyme Inhib. Med. Chem., 2021, 36(1), 1553-1563.
[http://dx.doi.org/10.1080/14756366.2021.1948841]
[http://dx.doi.org/10.1080/14756366.2021.1948841]
[3]
Rubio-Ruiz, B.; Serrán-Aguilera, L.; Hurtado-Guerrero, R.; Conejo-García, A. Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition. Med. Res. Rev., 2020, 41(2), 902-927.
[http://dx.doi.org/10.1002/med.21746]
[http://dx.doi.org/10.1002/med.21746]
[4]
Brancucci, N.M.B.; Gerdt, J.P.; Wang, C.; De, N.M.; Philip, N.; Adapa, S.R.; Zhang, M.; Hitz, E.; Niederwieser, I.; Boltryk, S.D.; Laffitte, M.C.; Clark, M.A.; Grüring, C.; Ravel, D.; Blancke, S.A.; Demas, A.; Bopp, S.; Rubio-Ruiz, B.; Conejo-Garcia, A.; Wirth, D.F.; Gendaszewska-Darmach, E.; Duraisingh, M.T.; Adams, J.H.; Voss, T.S.; Waters, A.P.; Jiang, R.H.Y.; Clardy, J.; Marti, M. Lysophosphatidylcholine regulates sexual stage differentiation in the human malaria parasite plasmodium falciparum. Cell, 2017, 171(7), 1544, e15.
[http://dx.doi.org/10.1016/j.cell.2017.10.020]
[http://dx.doi.org/10.1016/j.cell.2017.10.020]
[5]
Cruz-López, O.; Ramírez, A.; Navarro, S.A.; García, M.A.; Marchal, J.M.; Campos, J.M.; Conejo-García, A. 1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds. Future Med. Chem., 2017, 9(11), 1129-1140.
[6]
Serrán-Aguilera, L.; Denton, H.; Rubio-Ruiz, B.; López-Gutiérrez, B.; Entrena, A.; Izquierdo, L.; Smith, T.K.; Conejo-García, A.; Hurtado-Guerrero, R. Plasmodium falciparum choline kinase inhibition leads to a major decrease in phosphatidylethanolamine causing parasite death. Sci. Rep., 2016, 12(6), 33189.
[http://dx.doi.org/10.1038/srep33189]
[http://dx.doi.org/10.1038/srep33189]
[7]
Ramírez, A.; Boulaiz, H.; Morata-Tarifa, C.; Perán, M.; Jiménez, G.; Picon-Ruiz, M.; Agil, A.; Cruz-López, O.; Conejo-García, A.; Campos, J.M.; Sánchez, A.; García, M.A.; Marchal, J.A. HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib. Oncotarget, 2014, 5(11), 3590-3606.
[http://dx.doi.org/10.18632/oncotarget.1962]
[http://dx.doi.org/10.18632/oncotarget.1962]
[8]
Rubio-Ruiz, B.; Figuerola-Conchas, A.; Ramos-Torrecillas, J.; Capitán-Cañadas, F.; Ríos-Marco, P.; Carrasco, M.P.; Gallo, M.Á.; Espinosa, A.; Marco, C.; Ruiz, C.; Entrena, A.; Hurtado-Guerrero, R.; Conejo-García, A. Discovery of a new binding site on human choline kinase α1: design, synthesis, crystallographic studies, and biological evaluation of asymmetrical bispyridinium derivatives. J. Med. Chem., 2014, 57(2), 507-515.
[http://dx.doi.org/10.1021/jm401665x]
[http://dx.doi.org/10.1021/jm401665x]
[9]
Rubio-Ruiz, B.; Castillo-Acosta, V.M.; Pérez-Moreno, G.; Espinosa, A.; González-Pacanowska, D.; Ruiz-Pérez, L.M.; Entrena, A.; Conejo-García, A. In vitro antiplasmodial and cytotoxic activities of asymmetrical pyridinium derivatives. Eur. J. Med. Chem., 2014, 85, 289-292.
[http://dx.doi.org/10.1016/j.ejmech.2014.07.105]
[http://dx.doi.org/10.1016/j.ejmech.2014.07.105]
[10]
Sahún-Roncero, M.; Rubio-Ruiz, B.; Saladino, G.; Conejo-García, A.; Espinosa, A.; Velázquez-Campoy, A.; Gervasio, F.L.; Entrena, A.; Hurtado-Guerrero, R. The mechanism of allosteric coupling in choline kinase α1 revealed by the action of a rationally designed inhibitor. Angew. Chem. Int. Ed. Engl., 2013, 52(17), 4582-4586.
[http://dx.doi.org/10.1002/anie.201209660]
[http://dx.doi.org/10.1002/anie.201209660]
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Current Cancer Therapy Reviews
Current Drug Safety
Current Drug Targets
Recent Patents on Anti-Cancer Drug Discovery
Letters in Drug Design & Discovery
Current Drug Discovery Technologies
Current Radiopharmaceuticals
Related Books
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Advances in Organic Synthesis
Frontiers in Natural Product Chemistry
Recent Advances in Analytical Techniques
Frontiers in Drug Design and Discovery
NEOPLASIA and FERTILITY
Therapeutic Use of Plant Secondary Metabolites
Frontiers in Computational Chemistry
Frontiers in Bioactive Compounds
